Dow Jones

39 869,70

0,16%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Aeolus Pharmaceuticals Inc (CE) (AOLS)
Aeolus Pharmaceuticals Inc (CE) (AOLS) Actualités

AOLS

Aeolus Pharmaceuticals (CE) (AOLS)

Aeolus Pharmaceuticals Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:AOLS

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
22/12/2017	22h53	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
14/08/2017	23h09	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
24/03/2017	16h51	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
14/02/2017	17h17	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
30/01/2017	23h06	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
30/12/2016	22h55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
20/12/2016	23h28	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
20/12/2016	23h25	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
16/05/2016	23h09	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
19/04/2016	23h10	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
23/03/2016	21h49	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
16/02/2016	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
12/02/2016	22h32	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
18/12/2015	12h05	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
15/12/2015	21h24	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
17/02/2015	22h32	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
01/07/2014	13h30	Marketwired	Aeolus Announces Additional Data Demonstrating Efficacy of AEOL 10150 as a Medical Countermeasure Against Exposure to Nerve A...	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
18/06/2014	16h39	Marketwired	Aeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal CEES Model of Mustard Gas Skin Exposure	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
02/06/2014	22h32	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
02/06/2014	14h00	Marketwired	Aeolus Pharmateucticals to Present at LD Micro Invitational Conference	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
16/05/2014	01h03	Marketwired	Aeolus Announces Second Quarter Fiscal Year 2014 Financial Results and Achievements in Lung-ARS Development Program	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
28/03/2014	17h24	Edgar (US Regulatory)	Registration of Securities by Certain Investment Companies. Declaration of Election Rule 24f-2 Notice (24f-2nt)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
28/03/2014	17h24	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
14/02/2014	23h30	Marketwired	Aeolus Announces First Quarter Fiscal Year 2014 Financial Results	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
14/02/2014	23h00	Edgar (US Regulatory)	Mutual Fund Summary Prospectus (497k)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
14/02/2014	23h00	Edgar (US Regulatory)	Definitive Materials Filed by Investment Companies. (497)	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
13/02/2014	13h30	Marketwired	Aeolus Announces Process Improvements and Positive 18 Month Stability Results for AEOL 10150 in New Formulation	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
10/02/2014	13h30	Marketwired	Aeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal Model of Lung Radiation Exposure; Models ...	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
23/01/2014	16h52	Marketwired	Aeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDA	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)
23/12/2013	14h00	Marketwired	Aeolus Announces Fiscal Year 2013 Financial Results	USOTC:AOLS	Aeolus Pharmaceuticals Inc (CE)